# Sleep Disorders and Gastroesophageal Reflux Disease (GERD)

> **NCT00287391** · PHASE4 · COMPLETED · sponsor: **University of North Carolina** · enrollment: 20 (—)

## Conditions studied

- Insomnia
- GERD

## Interventions

- **DRUG:** Rabeprazole

## Key facts

- **NCT ID:** NCT00287391
- **Lead sponsor:** University of North Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 20 (—)
- **Last updated:** 2007-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287391, "Sleep Disorders and Gastroesophageal Reflux Disease (GERD)". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00287391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*